Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. April 2022 08:00 ET | Quelle: Neuronetics; Greenbrook TMS

Greenbrook and Neuronetics Announce Strengthened Commercial Partnership to Build Awareness

TORONTO and MALVERN, Pa., April 11, 2022 (GLOBE NEWSWIRE) -- Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared,...
08. März 2022 16:35 ET | Quelle: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
08. März 2022 07:30 ET | Quelle: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients...
03. März 2022 10:00 ET | Quelle: Neuronetics

NeuroStar® Advanced Therapy Launches New “Tap Into a New Possibility” Campaign for Depression Awareness

MALVERN, Pa., March 03, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
01. März 2022 08:31 ET | Quelle: Neuronetics

MT Cap for NeuroStar Advanced Therapy for Mental Health Now Available Nationwide

MALVERN, Pa., March 01, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
22. Februar 2022 16:30 ET | Quelle: Neuronetics

Neuronetics to Report Fourth Quarter and Fiscal Year 2021 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
22. Februar 2022 07:30 ET | Quelle: Neuronetics

Neuronetics Announces Amendment of Credit Facility with SLR Investment Corp.

MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
10. Januar 2022 08:31 ET | Quelle: Neuronetics

NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021

MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
10. Januar 2022 08:30 ET | Quelle: Neuronetics

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
20. Dezember 2021 08:31 ET | Quelle: Neuronetics

Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health

MALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...

Vorherige Seite